A Window of Opportunity Study of Pre-operative Endocrine Therapy With and Without Prometrium in Postmenopausal Women With Early Stage Breast Hormone Receptor Positive (HR+) Human Epidermal Receptor 2 Negative (HER2-) Breast Cancer.

Clinical trial NCT03906669 · UNKNOWN

Trial details

NCT number: NCT03906669
Sponsor: St Vincent's Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Early-stage Breast Cancer Hormone Receptor Positive Tumor

Start date: 2018-03-20
Primary completion: 2024-04-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.